Several experimental results demonstrated that T3-induced Bcl-xL, an antiapoptotic gene, prevented hepatoma cells from TRAIL-induced apoptosis, in turn promoting hepatoma cell metastasis. This evidence concerns the gene BCL2L1 and hepatocellular carcinoma.